An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
Researchers evaluated data from acute respiratory distress syndrome patients to see if it was possible to anticipate which ones would develop psychiatric symptoms.
RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.